GCBRO-FXTab.

Acebrophylline (SR) 200 mg + Fexofenadine HCI 120 mg +

Montelukast Sodium 10 mg Tablets

ACEBROPHYLLINE: Modifies mucus secretion by lowering viscosity & increases mucociliary clearance by augmenting ciliary motility

FEXOFENADINE : Significantly blocks the histamine H1 receptors in the airways

MONTELUKAST: Leukotriene receptor antagonist, Increases the long-term control of asthma in patients with moderate-to-servere asthma

In

• COPD/ASTHMA
• Acute/Chronic Bronchitis
• Recurrence of Chronic Bronchitis